Christine Chung, MD, Oncology, Tampa, FL, H. Lee Moffitt Cancer Center and Research Institute

ChristineHwayongChungMD

Oncology Tampa, FL

Head & Neck Cancer, Hematologic Oncology

Associate Professor of Oncology, Associate Professor of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine

Overview of Dr. Chung

Dr. Christine Chung is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from Eastern Virginia Medical School and has been in practice 19 years. Dr. Chung accepts several types of health insurance, listed below. She is one of 144 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. She also speaks multiple languages, including Korean.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFELLOWSHIP
  • University of North Carolina Hospitals
    University of North Carolina HospitalsRESIDENCY
  • Eastern Virginia Medical School
    Eastern Virginia Medical SchoolMEDICAL_SCHOOL
  • Johns Hopkins UniversityOTHER_TRAINING
  • University of California, Los AngelesOTHER_TRAINING

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2015 - 2021
  • MD State Medical License
    MD State Medical License 2010 - 2016
  • TN State Medical License
    TN State Medical License 2003 - 2010
  • NC State Medical License
    NC State Medical License 1999 - 2004
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • Fellowship Award for Research in Japan Japanese Society for the Promotion of Science, 2009
  • The Next Generation Award, Radiation Therapy Oncology Group RTOG, 2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Cleaved NOTCH1 expression pattern in head and neck squamous cell carcinoma is associated with NOTCH1 mutation, HPV status and high-risk clinical features  
    Rettig EM, Chung CH, Bishop JA, Howard JD, Sharma RB, Li RJ, Douville C, Karchin R, Izumchenko E, Sidransky D, Koch W, Califano J, Agrawal N, Fakhry C, Cancer Prev Res, 1/1/2015
  • A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma  
    Gilbert J, Schell MJ, Zhao X, Murphy B, Tanvetyanon T, Leon ME, Hayes DN, Haigentz M, Saba N, Nieva J, Bishop J, Sidransky D, Ravi R, Bedi A, Chung CH, Oral Oncol, 1/1/2015
  • Novel targets in head and neck cancer: Should we be optimistic?  
    Krigsfeld G, Chung CH, Clin Can Res, 1/1/2015
  • Join now to see all

Books/Book Chapters

Lectures

  • Ready for a Molecular Signature as a Prognostic/Predictive Biomarker? 
    Milan, Italy - 1/24/2014
  • What is the current and future role of systemic therapy in the TOS-treated patients? 
    Baltimore, MD - 1/24/2014
  • Benefits of genomic medicine: what to tell the patient. 
    Boston, MA - 1/14/2014
  • Join now to see all

Other

  • Supportive care for patients with head and neck cancer. Medscape Hematology-Oncology. 
    Murphy BA, Chung CH, Medscape, LLC
    1/1/2006

Press Mentions

  • Saliva HPV Test Ready for Prime Time in Head and Neck Cancer?
    Saliva HPV Test Ready for Prime Time in Head and Neck Cancer?March 28, 2019
  • Once a Vocational Nomad, Christine H. Chung, MD, Now Works to Promote Patient-Centered Care in Head and Neck Cancer
    Once a Vocational Nomad, Christine H. Chung, MD, Now Works to Promote Patient-Centered Care in Head and Neck Cancer
  • Vigilant Biosciences Names Scientific Advisory Board and Expands Leadership Team, Appoints Dr. Michael Donovan as Chief Clinical Officer
    Vigilant Biosciences Names Scientific Advisory Board and Expands Leadership Team, Appoints Dr. Michael Donovan as Chief Clinical OfficerMay 25, 2016

Other Languages

  • Korean

Hospital Affiliations

Insurance Accepted

  • BCBS Blue Card PPO
    CareFirst BCBS Maryland POS
    CareFirst BlueChoice Advantage
    CareFirst BlueChoice Network POS
    CareFirst BluePreferred PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Great West PPO
    Multiplan PHCS PPO
    Multiplan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment